ChemicalBook > CAS DataBase List > 9-Nitrominocycline

9-Nitrominocycline

Product Name
9-Nitrominocycline
CAS No.
149934-16-7
Chemical Name
9-Nitrominocycline
Synonyms
9-Nitro Minocycline;Tigecycline Impurity G;Tigecycline Impurity 12;GEGDTZYTPKKFGB-IRDJJEOVSA-N;TigecyclineImpurity12Hemisulfate;(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino);Minocycline Impurity 5(Minocycline 9-Nitro Impurity);Minocycline EP Impurity G Intermediate(9-Nitro Minocycline);Minocycline Impurity 5 Hemisulfate(Minocycline 9-Nitro Impurity Hemisulfate);Minocycline 9-Nitro ImpurityQ: What is Minocycline 9-Nitro Impurity Q: What is the CAS Number of Minocycline 9-Nitro Impurity
CBNumber
CB32622575
Molecular Formula
C23H26N4O9
Formula Weight
502.47
MOL File
149934-16-7.mol
More
Less

9-Nitrominocycline Property

Boiling point:
825.9±65.0 °C(Predicted)
Density 
1?+-.0.1 g/cm3(Predicted)
pka
4.50±1.00(Predicted)
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

9-Nitrominocycline Chemical Properties,Usage,Production

Uses

9-Nitrominocycline is used as a reagent in the preparation of tigecycline from minocycline hydrochloride.

Uses

9-Nitrominocycline is a 9-substituted Minocycline (M344800) derivative used as antibacterial agent.

Indications

Minoxidil, an antihypertensive agent, produces arteriolar vasodilation by an unknown mechanism. In limited clinical studies, minoxidil increases penile rigidity and has been used in the long-term treatment of organic impotence.

Biological Functions

Minoxidil (Loniten) is an orally effective vasodilator. It is more potent and longer acting than hydralazine and does not accumulate significantly in patients with renal insufficiency. It depends on in vivo metabolism by hepatic enzymes to produce an active metabolite, minoxidil sulfate. Minoxidil sulfate activates potassium channels, resulting in hyperpolarization of vascular smooth muscle and relaxation of the blood vessel.

Pharmacology

The hemodynamic effects of minoxidil are generally similar to those of hydralazine, with the noteworthy exception that a greater decrease in peripheral vascular resistance and consequently a larger reduction in blood pressure can be achieved with minoxidil. Minoxidil produces no important changes in either renal blood flow or glomerular filtration rate. It has little or no effect on venous capacitance and does not inhibit the reflex activation of the sympathetic nervous system. Orthostasis and other side effects of sympathetic blockade are therefore not a problem. As with hydralazine, there is a significant increase in cardiac output that is secondary to reflex increases in sympathetic activity, hyperreninemia, and salt and water retention.These effects can substantially reduce the effectiveness of minoxidil when it is used alone.The addition of a -blocker and a diuretic to the therapeutic regimen will preserve minoxidil’s antihypertensive action while attenuating some of the undesirable side effects.

Clinical Use

The major indications for the use of minoxidil are (1) severe hypertension that may be life threatening and (2) hypertension that is resistant to milder forms of therapy. Compromises in renal function do not prolong either the plasma or the therapeutic half-life of minoxidil, and therefore, it seems to be particularly important for hypertensive patients with chronic renal failure.

Side effects

Signs of toxicity common to vasodilator therapy in general also occur with minoxidil; they are attributable to vasodilation and reflex increases in sympathetic nerve activity. These include headache, nasal congestion, tachycardia, and palpitations. These effects do not have great clinical importance, since minoxidil is almost always administered in combination with a -blocker, which antagonizes the indirect cardiac effects. A more troublesome side effect, particularly in women, is the growth of body hair, possibly due to a direct stimulation of the growth and maturation of cells that form hair shafts. Apparently, minoxidil activates a specific gene that regulates hair shaft protein. In any case, this particular side effect has been capitalized upon, and minoxidil is now marketed as Rogaine for the treatment of male pattern baldness.

Metabolism

Peak concentrations of minoxidil in the blood occur 1 hour after oral administration, although the therapeutic effect may take 2 or more hours to manifest. This is probably related to the time it takes to convert minoxidil to minoxidil sulfate. The antihypertensive action after an oral dose of minoxidil lasts 12 to 24 hours. The long duration of action allows the drug to be administered only once or twice a day, a regimen that may be beneficial for compliance. Interestingly, the therapeutic half-life is considerably longer than the plasma half-life. This may be, as has been suggested for hydralazine, a result either of accumulation of the drug and its active metabolite in arterial walls or a longer plasma half-life of the sulfated metabolite, or both.
The ultimate disposition of minoxidil depends primarily on hepatic metabolism and only slightly on renal excretion of unchanged drug. Because of this, pharmacological activity is not cumulative in patients with renal failure.

9-Nitrominocycline Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

9-Nitrominocycline Suppliers

Chemsky (shanghai) International Co.,Ltd
Tel
021-50135380
Email
shchemsky@sina.com
Country
China
ProdList
15421
Advantage
60
ChemStrong Scientific Co.,Ltd
Tel
0755-0755-66853366 13670046396
Fax
0755-28363542
Email
sales@chem-strong.com
Country
China
ProdList
17993
Advantage
56
Hubei Yangxin Medical Technology Co., Ltd.
Tel
15374522761
Fax
QQ:2853117752
Email
3003392093@qq.com
Country
China
ProdList
8043
Advantage
55
Alchemist-pharm chemical Technology Co. Ltd.
Tel
0371-67991738 13783628208
Fax
QQ 412703949
Email
carl@alchemist-pharm.com
Country
China
ProdList
1877
Advantage
58
Shenzhen Polymeri Biochemical Technology Co., Ltd.
Tel
+86-400-002-6226 13028896684
Email
sales@rrkchem.com
Country
China
ProdList
56039
Advantage
58
Guangzhou Dreampharm Biotechnology Co., Ltd.
Tel
020-36607679 17825480238
Fax
QQ 3008233717
Email
3008233717@qq.com
Country
China
ProdList
9843
Advantage
12
Jinan blalong chemical co. LTD
Tel
2710913286@.com
Email
1513643261@qq.com
Country
China
ProdList
14253
Advantage
58
Energy Chemical
Tel
021-58432009 400-005-6266
Fax
021-58436166
Email
marketing1@energy-chemical.com
Country
China
ProdList
44843
Advantage
58
Guangzhou Juntang Technology Co., Ltd
Tel
020-36607679 13502246435
Email
sales@dmstandards.com
Country
China
ProdList
10951
Advantage
58
Foshan Treasure Biotechnology Co., Ltd
Tel
0757-85921206 18520245316
Email
2329783215@qq.com
Country
China
ProdList
12664
Advantage
58
Molcoo Chemicals Inc.
Tel
18627923403 18627753421
Email
3001006472@qq.com
Country
China
ProdList
8768
Advantage
58
Scinova Biotech(Guangzhou) Co., Ltd.
Tel
13268215580
Email
scinova_sales@163.com
Country
China
ProdList
7026
Advantage
58
HX Pharmaceutical technology co., LTD
Tel
15671363360
Email
494267389@qq.com
Country
China
ProdList
2431
Advantage
58
Hubei De'ao Chemical Research Pharmaceutical Technology Co., Ltd
Tel
18502726233
Email
3641133981@qq.com
Country
China
ProdList
9400
Advantage
58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd
Tel
18162595016
Email
3287908757@qq.com
Country
China
ProdList
9887
Advantage
58
Nantong Hanfang Biotechnology Co. , Ltd.
Tel
3674309880
Email
hanfangpharma@126.com
Country
China
ProdList
30968
Advantage
58
Hubei Moco Chemical Co., Ltd.
Tel
17386083646
Fax
QQ:3001051413
Email
2853567991@qq.com
Country
China
ProdList
10543
Advantage
58
Guangzhou PI PI Biotech Inc
Tel
+86-020-81716320 +86-13602409664
Fax
020-81716319
Email
Sales@pipitech.com
Country
China
ProdList
3635
Advantage
55
China National Standard Pharmaceutical Corporation Limited
Tel
+8615391658522
Email
overseasales@yongstandards.com
Country
China
ProdList
11927
Advantage
58

149934-16-7, 9-NitrominocyclineRelated Search:


  • Tigecycline Impurity G
  • (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)
  • Tigecycline Impurity 12
  • (4S,4aS,5aR,12aS)-4,7-Bis(diMethylaMino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-9-nitro-1,11-dioxo-2-naphthacenecarboxaMide
  • [4S-(4α,4aα,5aα,12aα)]-4,7-Bis(diMethylaMino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-9-nitro-1,11-dioxo-2-naphthacenecarboxaMide
  • 9-Nitro Minocycline
  • GEGDTZYTPKKFGB-IRDJJEOVSA-N
  • Minocycline Impurity 5(Minocycline 9-Nitro Impurity)
  • 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-9-nitro-1,11-dioxo-, (4S,4aS,5aR,12aS)-
  • Minocycline 9-Nitro ImpurityQ: What is Minocycline 9-Nitro Impurity Q: What is the CAS Number of Minocycline 9-Nitro Impurity
  • Minocycline EP Impurity G Intermediate(9-Nitro Minocycline)
  • (4S,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-3,10,12,12a-tetrahydroxy-9-nitro-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
  • TigecyclineImpurity12Hemisulfate
  • Minocycline Impurity 5 Hemisulfate(Minocycline 9-Nitro Impurity Hemisulfate)
  • 149934-16-7
  • Amines
  • Aromatics
  • Intermediates & Fine Chemicals
  • Pharmaceuticals